Insights into GABAAergic system deficits in fragile X syndrome lead to clinical trials.
about
Dysregulation and restoration of translational homeostasis in fragile X syndromeModeling Fragile X Syndrome Using Human Pluripotent Stem CellsThe GABAA receptor is an FMRP target with therapeutic potential in fragile X syndrome.GABAB receptor upregulates fragile X mental retardation protein expression in neuronsPositron Emission Tomography (PET) Quantification of GABAA Receptors in the Brain of Fragile X Patients.Dynamics of the ovarian reserve and impact of genetic and epidemiological factors on age of menopause.Monogenic mouse models of autism spectrum disorders: Common mechanisms and missing links.Immature Responses to GABA in Fragile X Neurons Derived from Human Embryonic Stem CellsEffects of early-life exposure to THIP on phenotype development in a mouse model of Rett syndrome.Phelan McDermid Syndrome: From Genetic Discoveries to Animal Models and Treatment.Fragile X Syndrome FMRP Co-localizes with Regulatory Targets PSD-95, GABA Receptors, CaMKIIα, and mGluR5 at Fiber Cell Membranes in the Eye Lens.Human pluripotent stem cells in modeling human disorders: the case of fragile X syndrome.A randomized double-blind, placebo-controlled trial of ganaxolone in children and adolescents with fragile X syndrome.Reduced Lateral Inhibition Impairs Olfactory Computations and Behaviors in a Drosophila Model of Fragile X Syndrome.Decreased surface expression of the δ subunit of the GABAA receptor contributes to reduced tonic inhibition in dentate granule cells in a mouse model of fragile X syndrome.GABAB receptor-mediated feed-forward circuit dysfunction in the mouse model of fragile X syndrome.Modeling Fragile X Syndrome in Drosophila.Animal Models for Neurodevelopmental DisordersFragile X syndrome
P2860
Q26782616-8B736063-8F9A-45D6-8B79-B89E4CEE9A09Q28080022-E76E07DC-B6EE-408A-84E9-B511E8EC31FFQ30385019-6639E3DC-1F23-456C-A9E3-FBCB9F0A2B54Q35659477-2F5DA6B7-0C0B-4508-AE08-19247B62BC4DQ35723110-C6A3640F-B280-460B-A7A8-944433E92BBDQ36282786-580174F5-85AC-4965-A5A1-52EE0E6DFE4AQ36716971-B1E80A2A-F332-4D84-8966-1DCA98202E46Q36892998-BD875FA5-0985-46CC-92E3-77E5CBAEDC08Q37349496-2796029A-EFA4-44F0-9A2E-0179E5E81CF5Q38583174-39484966-364D-4A09-BCF2-190F30C22C8AQ38971781-A45910D8-A107-4829-A050-298F4FC63A7EQ39024323-44B0A155-DFD1-47C5-AC96-7E3F9808D2DAQ41215871-1D89000B-6EB6-4D0D-BA8A-2E1764927F29Q42290506-CF8C94A8-7F40-4700-9998-9DE276A85F55Q45011378-B1DB6063-094B-484E-8F95-F194A2CE0517Q50573783-593C46DF-DC7E-4512-88B7-B97767B69FDDQ55119637-3C6A9015-0C95-4965-B1DD-67DAD25E6805Q57279115-4DA07A61-8567-40C2-AAEA-B60CB0087C1BQ57828399-EF7D11D9-542C-43AB-851C-EF22AE25CA45
P2860
Insights into GABAAergic system deficits in fragile X syndrome lead to clinical trials.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Insights into GABAAergic system deficits in fragile X syndrome lead to clinical trials.
@en
type
label
Insights into GABAAergic system deficits in fragile X syndrome lead to clinical trials.
@en
prefLabel
Insights into GABAAergic system deficits in fragile X syndrome lead to clinical trials.
@en
P1433
P1476
Insights into GABAAergic system deficits in fragile X syndrome lead to clinical trials.
@en
P2093
Sien Braat
P356
10.1016/J.NEUROPHARM.2014.06.028
P50
P577
2014-07-10T00:00:00Z